Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.
Mol Pharm
; 18(1): 338-346, 2021 01 04.
Article
in En
| MEDLINE
| ID: mdl-33289569
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peptides
/
Cell Nucleus
/
Tumor Suppressor Protein p53
/
Triple Negative Breast Neoplasms
/
Antineoplastic Agents
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Mol Pharm
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACIA
/
FARMACOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: